samples-publish2024-06-04-D.BSRA.xlsx
BSRA-WBA-2
WBA_180919-BSRA-FcEngineered-EI.xlsx
https://immport.org/shared/study/SDY2541
fc1fb6a448d4081b51af26b2b612b0e4
MD5
BAC-240502ALT-3; TIS-240502ALT-1; AB-220920ALT-1; AB-220921ALT-1; AB-220920ALT-2; AB-220920ALT-3; AB-220920ALT-4; AB-220920ALT-5; AB-220920ALT-6; AB-220920ALT-7; AB-220920ALT-8; AB-220920ALT-9; AB-220920ALT-10; AB-220920ALT-11; AB-220920ALT-12; AB-220920ALT-13; AB-220920ALT-14; AB-220920ALT-15; AB-220920ALT-16; AB-220920ALT-17; AB-220920ALT-18; AB-220920ALT-19; AB-220920ALT-20; AB-220920ALT-21; AB-220920ALT-22; AB-220920ALT-23; AB-220920ALT-24; AB-220920ALT-25; AB-220920ALT-26; AB-220920ALT-27; AB-220920ALT-28; AB-220920ALT-29; AB-220920ALT-30; AB-220920ALT-31; AB-220920ALT-32; AB-220920ALT-33; AB-220920ALT-34; AB-220920ALT-35; AB-220920ALT-36; AB-220920ALT-37; AB-220920ALT-38; AB-220920ALT-39; AB-220920ALT-40; AB-220920ALT-41; AB-220920ALT-42; AB-220920ALT-43; AB-220920ALT-44; AB-220920ALT-45; AB-220920ALT-46; AB-220920ALT-47; AB-220920ALT-48; AB-220920ALT-49; AB-220920ALT-50; AB-220920ALT-51; AB-220920ALT-52; AB-220921ALT-2
Eddie Irvine
2018-09-19T0:0:0+0000
https://fairdomhub.org/sops/729
Whole Blood Restriction Assay
https://www.addgene.org/26161/
Photorhabdus luminescens
H37Rv Mtb-Lux
1.0x10^6 bacteria per mL of blood
Human whole blood cells
N/A
N/A
N/A
N/A
N/A
Immediately after infection, then every 24 hours up to 120 hours
Tecan Spark 10M
Tecan
Antibody treatments at 25ug/mL in 300µL total volume; Rifampin at 0.25ug/mL
Creators
Not specifiedSubmitter
Views: 57
Created: 6th Jun 2024 at 15:05
This item has not yet been tagged.
None